Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
95.06 USD | +2.66% | +0.41% | +10.85% |
05:22pm | Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating | MT |
09/05 | Transcript : Haemonetics Corporation, Q4 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.85% | 4.7B | |
-4.68% | 182B | |
+0.11% | 110B | |
-3.99% | 67.92B | |
+3.01% | 50.96B | |
+9.67% | 44.7B | |
+2.70% | 40.66B | |
+20.72% | 27.6B | |
+4.15% | 26.63B | |
-0.46% | 24.98B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Citigroup Boosts Price Target on Haemonetics to $92 From $88, Affirms Neutral Rating